ALLERGY UNLOCKED
LIVE

Serial Number

79154606

Owner

ALK-Abelló A/S

Attorney

B. Brett Heavner

Filing Date

Apr 10, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ALLERGY UNLOCKED Trademark

Serial Number: 79154606 • Registration: 4774784

ALLERGY UNLOCKED is a trademark filed by ALK-Abelló A/S on April 10, 2014. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ALK-Abelló A/S (37 trademarks)

Bøge Allé 6-8
DK-2970 Hørsholm , DK

Entity Type: 99

Trademark Details

Filing Date

April 10, 2014

Registration Date

July 21, 2015

Published for Opposition

May 5, 2015

Cancellation Date

April 10, 2024

Goods & Services

Medical diagnostic test kits sold empty for diagnosing allergies; inhalers for medical purposes; medical syringes and medical fluid injectors for treatment of anaphylactic reactions; medical fluid injectors intended for pharmaceutical preparations, substances and medicines, particularly adrenaline for use in the treatment of allergies, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; hypodermic injectors and holders for hypodermic injectors, namely, hypodermic needles and hypodermic syringes; structural parts and fittings for all the aforesaid goods

Scientific, technological, medical and pharmacological research services and design relating thereto, namely, scientific research, medical research and pharmaceutical research services; scientific and medical laboratory services; conducting clinical trials for others

Pharmaceutical and veterinary preparations, namely, pharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposes, namely, diagnostic preparations for the treatment, monitoring and diagnosing of diseases such as allergies, asthma, rhinitis and respiratory diseases, diagnostic reagents for medical use; pharmaceutical preparations in the form of injectable pharmaceuticals, particularly adrenaline, for treatment of anaphylactic reactions; prefilled injectors containing pharmaceutical preparations, substances and medicines, particularly adrenaline

Chemicals used in research and science; diagnostic preparations for scientific or research purposes

Medical services and medical healthcare services; medical consulting services, namely, counselling and information regarding immunotherapy, allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions, also electronically or digitally, namely, medical consultations; providing medical information to medical professionals relating to immunotherapy as well as to diagnosing, prevention and treatment of allergy, asthma, allergic rhinitis, allergic asthma, respiratory allergic diseases and anaphylactic reactions, also electronically or digitally, through a website; medical diagnostic services, namely, performing diagnosis of diseases

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 1, 2024 DENA
DEATH OF INTERNATIONAL REGISTRATION
Nov 1, 2024 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Nov 20, 2022 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Oct 26, 2022 INTS
INVALIDATION PROCESSED
Oct 26, 2022 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Oct 4, 2022 INTR
CANCELLED SECTION 71
Feb 4, 2022 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 21, 2020 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Jan 23, 2020 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Sep 15, 2016 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jan 31, 2016 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Dec 10, 2015 XXSS
GENERIC MADRID TRANSACTION CREATED
Dec 10, 2015 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 21, 2015 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 21, 2015 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 5, 2015 NPUB
PUBLISHED FOR OPPOSITION
May 5, 2015 PUBO
NOTIFICATION PROCESSED BY IB
May 2, 2015 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 15, 2015 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 15, 2015 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 15, 2015 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 31, 2015 PREV
ATTORNEY REVIEW COMPLETED
Mar 31, 2015 ATRV
ASSIGNED TO LIE
Mar 17, 2015 ALIE
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Mar 17, 2015 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Mar 12, 2015 CRCV
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2015 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2015 TROA
REFUSAL PROCESSED BY IB
Dec 19, 2014 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 29, 2014 RFCS
REFUSAL PROCESSED BY MPU
Nov 29, 2014 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 26, 2014 RFCR
NON-FINAL ACTION WRITTEN
Nov 25, 2014 CNRT
APPLICATION FILING RECEIPT MAILED
Nov 22, 2014 MAFR
ASSIGNED TO EXAMINER
Nov 18, 2014 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 18, 2014 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Nov 17, 2014 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 13, 2014 REPR